Non-Small Cell Lung Cancer Pancreatic Cancer New Drug: Zenocutuzumab for advanced NRG1 fusion positive NSCLC and Pancreatic Cancer Ulas D. Bayraktar, MD 2024-12-06
GastroEsophageal Cancer New Drug: Zolbetuximab with FOLFOX for Gastric and GE Junction Cancer Ulas D. Bayraktar, MD 2024-11-11
Non-Small Cell Lung Cancer New Indication: Osimertinib after Chemoradiotherapy in NSCLC Ulas D. Bayraktar, MD 2024-09-30
Non-Small Cell Lung Cancer New Drug: Lazertinib for EGFR mutated NSCLC Ulas D. Bayraktar, MD 2024-08-27
Mesothelioma New Reference: Pembrolizumab with CISplatin and PEMEtrexed in Mesothelioma Ulas D. Bayraktar, MD 2024-06-22
Non-Small Cell Lung Cancer New Drug: Repotrectinib for ROS1-fusion positive NSCLC Ulas D. Bayraktar, MD 2024-06-21
Small Cell Lung Cancer New Indication: Repotrectinib for NTRK-Fusion Positive Solid Tumors Ulas D. Bayraktar, MD 2024-06-21
Uterine Cancer New Protocol: Durvalumab with CARBOplatin and PACLitaxel for Endomterial Cancer Ulas D. Bayraktar, MD 2024-06-21
